Thomson Medical Group Ltd. · SGX:A50

Thomson Medical — Shareholder Meeting (October 2024)

15 slides from Thomson Medical's shareholder meeting presentation, Oct 30, 2024

  1. Slide 1: 24th Annual General Meeting

    Confidential 24th Annual General Meeting Singapore Date: Wednesday, 30 Oct 2024 Time: 3.00 p.m.

  2. Slide 2: Disclaimer

    Confidential Disclaimer ANNOUNCEMENT SHALL NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES OR ELSEWHERE. For the purposes of this disclaimer, this presentation (“Presentation”) shall mean and include the slides herei

  3. Slide 3: FY2024 Financial Highlights

    Confidential FY2024 Financial Highlights 3

  4. Slide 4: Group Financial Highlights – FY2024

    Confidential Group Financial Highlights – FY2024 Profitability Financial Position Cash Flows 1.3% decrease in Revenue from Cash position of $167.3m Interest expenses of $51.6m $355.8m in FY2023 to $351.2m in FY2024 Debt of $1.1b Net cash outflow of Goodwill of $880.5m $125.3m 0.9% decrease in EBITDA

  5. Slide 5: Historical Financial Highlights

    Confidential Historical Financial Highlights REVENUE ($mil) ADJUSTED EBITDA ($mil) PROFIT AFTER TAX ($mil) YoY YoY YoY  52.5%  1.3%  3.1% 58.6 355.8 109.7 106.5 109.8 41.1 333.7 351.2 13.3 - - - 0.4 - 0.4 0.3 - 15.5 11.7 50.4 22.1 24.4 95.0 78.8 YoY YoY 19.5  5.5%  9.9 YoY 4.1 100.1 10.8% 70.0

  6. Slide 6: Business Segments – FY2024

    Confidential Business Segments – FY2024 1 REVENUE ADJUSTED EBITDA $50.4m $24.4m $22.1m 14.4% $95.0m 22.2% $100.1m 20.7% ($2.7m) 26.7% 28.5% $9.9m -2.5% 9.0% FY24 FY23 FY24 FY23 S$351.2m S$355.8m S$109.8m S$106.6m $24.5m 22.3% $51.1m $200.3m $260.4m 46.5% $87.1m 57.0% 73.2% 81.7% Singapore Malaysia V

  7. Slide 7: Key Operating Statistics

    Confidential Key Operating Statistics FY2021 FY2022 FY2023 FY2024 LICENSED BEDS1 Singapore 187 187 187 187 Malaysia 205 308 350 373 Vietnam4 - - - 230 Total 392 495 537 790 OPERATIONAL BEDS2 Singapore 181 181 178 178 Malaysia 170 299 314 341 Vietnam4 - - - 198 Total 351 480 492 717 BOR3 Singapore 55

  8. Slide 8: Key Operating Statistics

    Confidential Key Operating Statistics FY2021 FY2022 FY2023 FY2024 NUMBER OF INPATIENT Singapore 20,402 20,972 20,315 17,601 Malaysia 18,806 23,107 29,390 31,052 Vietnam2 N.A. N.A. N.A. 3,300 Total 39,208 44,079 49,705 51,953 NUMBER OF OUTPATIENT Singapore 277,398 308,308 288,638 252,071 Malaysia 166

  9. Slide 9: Business Overview, Updates and Growth Plans

    Confidential Business Overview, Updates and Growth Plans 9

  10. Slide 10: Key Businesses

    Confidential Key Businesses 100% ▪ One of the largest private providers of healthcare services for women and children in Singapore ▪ 37 clinics and centres today compared to 16 in 2010 S$200m FY24 Revenue ▪ Multi-disciplinary healthcare company listed on Bursa Malaysia ~70% ▪ Operates Thomson Hospit

  11. Slide 11: Thomson Medical Pte Ltd (TMPL)

    Confidential Thomson Medical Pte Ltd (“TMPL”) Singapore Hospital Operations & Ancillary Services 187 licensed beds(1) 37 clinics & centres Established in 1979, TMPL owns and operates Thomson Medical Centre (“TMC”) and a network of specialist Sembawang medical clinics and facilities providing outpati

  12. Slide 12: TMC Life Sciences Berhad (TMCLS)

    Confidential TMC Life Sciences Berhad (“TMCLS”) Malaysia Hospital Operations & Ancillary Services 373 licensed beds(1)(2) 5 fertility centres In 2008, TMCLS established Thomson Hospital Kota Damansara (“THKD”). THKD is its flagship multi-disciplinary tertiary care centre equipped with advanced medic

  13. Slide 13: Far East Medical Vietnam Limited (FEMVN)

    Confidential Far East Medical Vietnam Limited (“FEMVN”) Hospital Operations & Ancillary Services Vietnam 230 5 In 2008, FEMVN established Franco-Vietnamese Hospital (“FV Hospital”). As the first JCI accredited hospital in licensed beds(1) clinics & centres South Vietnam, FV Hospital is known for its

  14. Slide 14: TMG Going Forward: Building for Long-Term Growth

    Confidential TMG Going Forward: Building for Long-Term Growth • Strategic high-value healthcare markets high demand for premium healthcare services. • Markets offering high growth potential, capitalizing the Group’s established presence and expertise Regional in Singapore, Malaysia and Vietnam. Expa

  15. Slide 15: THANK YOU!

    Confidential THANK YOU! 24th Annual General Meeting Presentation ir@thomsonmedical.com 15

Thomson Medical Group — Shareholder Meeting (October 2024) on 6ix